The QVue app has you covered
- Test seamlessly
- Animated steps guide you through the testing process
- Animated steps guide you through the testing process
- Share results
- Easily share your results with anyone, anytime, directly from the app
- Easily share your results with anyone, anytime, directly from the app
- Access results
- Save test results for you and your family, making them accessible and shareable whenever needed
Optimize your testing experience
:16-9?wid=400&hei=225)
Test with confidence
Get the QVue app and have everything you need for your best testing experience
Disclaimer: The QVue app is supported on iOS 13 or newer for Apple iPhones and Android 9 or newer for Android Phones.
App Store and the Apple Logo are trademarks of Apple Inc.
Google Play and the Google Play Logo are trademarks of Google LLC.
QVue app general FAQs
The QVue app is not required to take your QuickVue COVID-19 Test, but it can make your testing experience less stressful and increase confidence in your result. The app provides clear, visual, step-by-step instructions from opening your test through result interpretation, taking the guesswork out of testing and helping ensure your test and results are valid.
By completing your test with the QVue app, you can easily access a history of results for you and your family from a single place and share a record of your results with whomever, whenever you want. For new and experienced testers, the QVue app provides an easy and stress-free way to test for COVID-19.
QVue makes it convenient and super easy to share a record of your result to whomever, whenever you want. Select the “Test Result” tab on the menu, choose the user, and then select the specific result from your history that you want to share. It’s as easy as sharing a photo with a friend. Select “Share,” then choose who you want to send it to and how—text, e-mail, or another app enabled on your phone.
Share your test results with public health authorities
Prevent the spread of COVID-19 and support contact-tracing efforts by reporting your results.
Our QuickVue At-Home OTC COVID-19 Test has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) under the new name – QuickVue COVID-19 Test, and will be available in late 2024.
Please note that the following information applies exclusively to the EUA (Emergency Use Authorization) product:
The QuickVue At-Home OTC COVID-19 Test is a lateral flow immunoassay device intended for the qualitative detection of nucleocapsid protein antigen from SARS-CoV-2.
This test is authorized for non-prescription home use with self-collected direct anterior nasal (nares) swab samples from individuals aged 14 years or older or adult-collected anterior nasal (nares) swab samples from individuals aged two years or older. This test is authorized for individuals with symptoms of COVID-19 within the first six days of symptom onset when tested at least twice over three days with at least 48 hours between tests, and for individuals without symptoms or other epidemiological reasons to suspect COVID-19, when tested at least three times over five days with at least 48 hours between tests. The QuickVue At-Home OTC COVID-19 Test does not differentiate between SARS-CoV and SARS-CoV-2.
*In the U.S., this product has not been FDA cleared or approved but has been authorized by FDA under an Emergency Use Authorization. This product has been authorized only for the detection of proteins from SARS-CoV-2, not for any other viruses or pathogens. The emergency use of this product is only authorized for the duration of the declaration that circumstances exist justifying the authorization of emergency use of in vitro diagnostics for detection and/or diagnosis of COVID-19 under Section 564(b)(1) of the Federal Food, Drug and Cosmetic Act, 21 U.S.C. § 360bbb-3(b)(1), unless the declaration is terminated or authorization is revoked sooner.
